Koers Chengdu Kanghua Biological Products Co., Ltd.
Aandelen
300841
CNE100003Y57
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
59,6 CNY | -0,13% | +6,39% | -23,14% |
Omzet 2024 * | 1,81 mld. 250 mln. 233 mln. | Omzet 2025 * | 2,1 mld. 290 mln. 270 mln. | Marktkapitalisatie | 7,97 mld. 1,1 mld. 1,03 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 711 mln. 98,14 mln. 91,48 mln. | Nettowinst (verlies) 2025 * | 815 mln. 112 mln. 105 mln. | EV/omzet 2024 * | 4,41 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 3,8 x |
K/w-verhouding 2024 * |
11,3
x | K/w-verhouding 2025 * |
9,86
x | Werknemers | 672 |
Dividendrendement 2024 * |
2,37% | Dividendrendement 2025 * |
2,7% | Vrij verhandelbaar | 63,47% |
1 dag | -0,13% | ||
1 week | +6,39% | ||
Lopende maand | +7,35% | ||
1 maand | +2,67% | ||
3 maanden | -2,77% | ||
6 maanden | -5,32% | ||
Lopend jaar | -23,14% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Qing Han Wang
CEO | Chief Executive Officer | 50 | 01-05-17 |
Wen Nian Wu
DFI | Director of Finance/CFO | 41 | 01-06-10 |
Wen Li Hou
BRD | Director/Board Member | 41 | 01-05-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Xiao Bo Fang
BRD | Director/Board Member | 50 | 01-03-20 |
Zhen Tao Wang
CHM | Chairman | 58 | - |
Xiong Ping Yu
BRD | Director/Board Member | 48 | 01-05-17 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.15% | 12 M€ | -16,71% | - | |
0.00% | 34 M€ | +2,22% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 59,6 | -0,13% | 2 292 500 |
24-04-24 | 59,68 | +4,72% | 3 233 532 |
23-04-24 | 56,99 | -1,74% | 2 059 028 |
22-04-24 | 58 | +4,04% | 2 044 265 |
19-04-24 | 55,75 | -0,48% | 1 179 275 |
slotkoers Shenzhen S.E., 25 april 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-23,14% | 1,1 mld. | |
-4,64% | 87,31 mld. | |
+2,63% | 40,86 mld. | |
-21,76% | 29,36 mld. | |
+58,56% | 24,49 mld. | |
-14,78% | 17,31 mld. | |
-18,49% | 11,62 mld. | |
-15,61% | 11,31 mld. | |
-44,02% | 11,26 mld. | |
+5,17% | 8,31 mld. |